Article
Considerations in Testing for Inherited Breast Cancer Predisposition in the Era of Personalized Medicine.
Surgical oncology clinics of North America - 1 Jan 2018
Powers Benjamin, Pal Tuya, Laronga Christine
Abstract excerpt
Technological advances realized through next-generation sequencing technologies coupled with the loss of the ability to patent genes have led to reduction in costs for genetic testing. As a result, more people are being identified with inherited breast cancer syndromes that may affect recommendations for surveillance and risk reduction. Surgeons, at the forefront for patients newly diagnosed with breast cancer,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
